7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia
IS38. Chronic Episodic Disorders: Comorbidity and Comprehensive Integrated Treatment (Part 1) Supported by GlaxoSmithKline
A. Unraveling the Complexity: Comorbidity, Mechanistic Link, and Pharmacologic Response Anita H. Clayton, M.D.
B. The Relationship Between Psychiatric Illness and Irritable Bowel Syndrome R. Bruce Lydiard, M.D.
C. Management of Pain Syndromes: Fibromyalgia, Migraines, and Chronic Pain Diane S. Thompson, M.D.
IS39. Age, Gender, and Diagnosis: Influences on Drug Response (Part 1) Supported by Pfizer Inc.
A. Epidemiology, Course, and Drug Response: How Are Mood and Anxiety Disorders Different in Children? John S. March, M.D.
B. Treatment of Mood Disorders in Women Kimberly A. Yonkers, M.D.
IS40. Therapeutic Challenges, Novel Approaches: Antipsychotics in the Management of Mood and Anxiety Disorders (Part 1) Supported by Eli Lilly and Company
A. Pharmacological Properties of Antipsychotics: Teasing Out Potential Mechanisms of Action Michael J. Owens, Ph.D.
B. Augmentation Strategies to Expand Pharmacotherapeutic Potential in Treatment-Refractory Major Depression Richard C. Shelton, M.D.
C. Psychotic Features in Illness Severity in Combat Veterans With Chronic PTSD Frederick Petty, M.D.
IS41. The Pathophysiology and Treatment of Impulsivity and Aggression in Psychiatric Disorders (Part 1) Supported by Abbott Laboratories
A. Mechanisms of Impulsivity Alan C. Swann, M.D.
B. Aggression, Violence, and Psycho-pathology: A Developmental Approach Hans Steiner, M.D.
IS42. New Perspectives on Schizophrenia Spectrum Disorders and Their Treatment (Part 1) Supported by Janssen Pharmaceutica
A. Neurobiology and Pharmacologic Treatment of Schizotypal Personality Larry J. Siever, M.D.
B. Cognitive Enhancers in the Schizophrenia Spectrum Marianne Goodman, M.D.
C. The Promise of Atypical Antipsychotics for Borderline Disorders S. Charles Schulz, M.D.
7:30 a.m.-5 p.m.
Registration/Course Enrollment Open
CME Courses 79-83
8 a.m.-5 p.m.
CME Course 84
9 a.m.-10:30 a.m.
Clinical Case Conference
3. Robert M. Weinrieb, M.D., and Deborah H.A. Van Dorn, Ph.D., on Motivational Enhancement Therapy for the Medically Ill, Substance Abuse Patient With Depression (Open to APA members only.)
20. Alan F. Schatzberg, M.D., on Essentials of Clinical Psychopharmacology (Meet the Authors)
21. Jesse S. Rosenthal, M.D., on Psychopharmacologic Treatment of Comorbid Attention Disorders in Adults
22. Peter A. Shapiro, M.D., on Psychiatric Aspects of Cardiovascular Disease
23. Norman A. Clemens, M.D., on the APA Business Initiative and the Future of Psychiatric Practice
L15. Evil in the World and Terror in Our Nation: Transferring Vulnerabilities Into Resilience: Philip G. Zimbardo, Ph.D.
L16. The Nearly Forgotten Factor in Psychiatry: What a Difference a Decade Makes David B. Larson, M.D.,APA’s Oskar Pfister Award Lecture
L17. Terror, Horror, and Fright: Past and Current Perspectives: Lenore C. Terr, M.D., APA’s Marmor Award Lecture
L18. Title to Be Determined David Satcher, M.D., APA’s Mental Health Patient Advocacy Lecture
Master Educator Clinical Consultations
9. Carol C. Nadelson, M.D., on Changing and Evolving Roles for the Clinicians (Open to APA members only.)
10. Barbara A. Schindler, M.D., on the Addicted Woman: Diagnostic and Treatment Challenges (Open to APA members only.)
11. Eric R. Marcus, M.D., on Adults With Learning Disabilities and Mood Disorders (Open to APA members only.)
Session 18. Soul of a Sister
25. Leona’s Sister Gerri
Session 19. Denying the Demon
CW32. Competence Requirements in Resident Education: Progress and Problems APA Committee on Graduate Education Chairperson: Sherwyn M. Woods, M.D.
CW33. Quality Indicators for Children and Adolescents: Who Cares? APA Council on Quality Improvement Chairperson: James C. MacIntyre II, M.D.
CW34. Practicing Rewarding Psychiatry in Jails and Prisons: A Practicum APA Council on Psychiatric Services Chairperson: Henry C. Weinstein, M.D.
CW35. Whose Children? Psychiatry in the Cultural Mosaic of America’s Schools APA Committee on Psychiatry and Mental Health in the Schools Chairperson: Mary E. Schwab-Stone, M.D.
CW36. It’s Not Gay Enough: Interpreting Antigay Bias in the 21st Century APA Committee on Gay, Lesbian, and Bisexual Issues Chairperson: Jack Drescher, M.D.
CW37. Dynamic Duel: Dilemmas of Split Treatment APA Consortium on Treatment Issues Co-Chairpersons: Sally L. Godard, M.D., Richard J. Kessler, D.O.
CW38. Talking With the Terminally Ill About Death and Dying APA Committee on End-of-Life Issues Co-Chairpersons: Maurice D. Steinberg, M.D., Edwin H. Cassem, M.D.
CW39. Psychologist Prescription Privileges: Is It Coming? Should It? APA Commission on Public Policy, Litigation, and Advocacy Co-Chairpersons: Amin N. Azzam, Raymond J. Kotwicki, M.D.
CW40. Combined Residency Training: You Want to Do What? APA Committee on Consultation-Liaison Psychiatry and Primary Care Education Co-Chairpersons: Shannon T. Suo-Chan, M.D., Susan L. Padrino, M.D.
CW41. The Rules of the Club: Career Advancement for Women APA Committee on Women Co-Chairpersons: Donna E. Stewart, M.D., Anu A. Matorin, M.D.
IW69. Treating Gay and Lesbian Youth at Risk Co-Chairpersons: William Resnick, M.D., Steven Sokoll, M.D.
IW70. Grievous Bodily Harm and Club Drugs: Treatment and Other Considerations Chairperson: Jeffrey N. Wilkins, M.D.
IW71. Recent Studies on Parity and Employer-Sponsored Insurance Substance Abuse and Mental Health Services Administration Chairperson: Darrel A. Regier, M.D.
IW72. Psychopharmacogenetics and Ethnicity: Current Perspectives Co-Chairpersons: Pedro Ruiz, M.D., Keh-Ming Lin, M.D.
IW73. Practical Pharmacotherapy of Mood Disorders Co-Chairpersons: Gary E. Miller, M.D., Richard L. Noel, M.D.
IW74. Mindfulness and Awareness Practice in the Medicine Buddha Tradition of Tibet Chairperson: James T. Sacamano, M.D.
IW75. Drug Therapy for Functional Somatic Syndromes Chairperson: Peter Manu, M.D.
IW76. In Search of the Empathic Healer Chairperson: Michael J. Bennett, M.D.
IW77. Disability Myths: Understanding the Social Security Administration Disability Program Chairperson: Bernard J. Arseneau, D.O.
IW78. New Directions in Mental Health Response to Disasters and Large-Scale Crises Substance Abuse and Mental Health Services Administration Chairperson: Mary E. Nelson, M.S.W.
IW79. Childhood Trauma Intervention and Aftermath: Access to Quality Care Substance Abuse and Mental Health Services Administration Chairperson: Malcolm A. Gordon, Ph.D.
IW80. Teaching Behavioral Sciences to Family Doctors Chairperson: Jonathan S. Davine, M.D.
IW81. Music as Mirror: Reflections of the Psyche in Works by the Great Composers Chairperson: Chelsea L. Chesen, M.D.
IW82. Assisting Physicians and Other Professionals Who Violate Boundaries Chairperson: Werner Tschan, M.D.
IW83. Women and Smoking Co-Chairpersons: Sarah M. Whitman, M.D., David Rubenstein, Psy.D.
IW84. Clozapine Use in HIV Chairperson: Richard H. McCarthy, M.D.
IW85. Intergenerational Aspect of Trauma and Trauma-Related Behavioral Patterns Chairperson: Andrei Novac, M.D.
IW86. Do Restricted Formularies Serve as Barriers to Care? Co-Chairpersons: Mitchel J. Stein, M.D., Joseph R. Mawhinney, M.D.
IW87. Advocacy 101: Influencing Mental Health Policy Chairperson: Jay B. Cutler, J.D.
IW88. Career Development and Risk Management Chairperson: Barry W. Wall, M.D.
Continuous Clinical Case Conference
Richard G. Hersh, M.D., and Mary S. Sciutto, M.D., on Managing Negative Outcomes in General Psychiatry: Part I (Open to APA members only.)
9 a.m.-12:30 p.m.
Review of Psychiatry: Section 3: Psychiatry in Medicine Chairperson: Nada L. Stotland, M.D.
Psychiatric Disorders and the Menstrual Cycle Laura J. Miller, M.D.
Psychiatric Factors in Solid Organ Transplantation Catherine A. Crone, M.D.
Gastroenterology Thomas N. Wise, M.D.
Mind and Heart: The Interplay Between Psychiatric and Cardiac Illness Theodore A. Stern, M.D.
9 a.m.-4 p.m.
CME Courses 85-90
10 a.m.-3 p.m.
Exhibits Open (last day)
Publishers’ Bookfair Open (last day)
APA Resources Center Open (last day)
11 a.m.-12:30 p.m.
L19. Can the Third Millennium Psychiatrist Help Persons at the End of Life? Edwin H. Cassem, M.D.,Distinguished Psychiatrist Lecture Series
L20. Journey to the West: Reflections on Culture and Psychiatry Entering the New Century: Keh-Ming Lin, M.D.,APA’s Kun-Po Soo Award Lecture
L21. Healing the Soul in the Age of the Brain: Reflecting on the Meaning of Psychiatry After September 11 Elio J. Frattaroli, M.D.
Master Educator Clinical Consultation
12. Michelle T. Pato, M.D., on Obsessive Compulsive and Related Disorders (Open to APA members only.)
Session 20. Growing Up Gay
27. "In the Life" television news magazine
Medical Update 3. Carol Lippa, M.D., on Strategic Update of Alzheimer’s Disease: Linking Disease With Therapeutics
Research Consultation 2. Raquel E. Gur, M.D., on Brain Behavior Studies in Schizophrenia
Scientific and Clinical Report Sessions
Session 25. Treatment of Personality Disorders
72. Risperidone Treatment of Schizotypal Personality Disorder Harold W. Koenigsberg, M.D.
73. A Preliminary Trial of Omega-3 Fatty Acids in Women With BPD Mary C. Zanarini, Ed.D.
74. Is Chemical Imbalance a Useful Concept in Treating Personality Disorders? Kenneth R. Silk, M.D.
Session 26. Issues in Child Psychiatry
75. ADHD Comorbidity: Age and Gender Differences Atilla Turgay, M.D.
76. Psychiatric Diagnosis for Children Under Age 5 Referred to a Public Mental Health System Harry H. Wright, M.D.
77. Modafinil in Children With ADHD: A Double-Blind, Placebo-Controlled Study Thomas A. Rugino, M.D.
Session 27. Psychotherapies
78. Music Therapy and Medication Compliance in Psychotic Patients Ruby C. Castilla-Puentes, M.D.
79. Controlled Study of NAMI Family-to-Family Education Program Lisa B. Dixon, M.D.
80. An Additional Guideline for Choosing Appropriate Supportive Psychotherapy Techniques Frederick S. Mendelsohn, M.D.
Session 28. Addiction Psychiatry
81. Ecstasy: Complications and Neurotoxicity Tina M. Vreys, M.D.
82. Predicting Treatment Outcome of Cocaine-Dependent Patients Ashwin A. Patkar, M.D.
83. 5HT Uptake, Impulsivity, Aggression, and Craving Among Cocaine Abusers Ashwin A. Patkar, M.D.
Session 29. Issues in Psychiatric Treatment
84. Civil Commitment in Turkey: Reflections on a Bill Drafted by Psychiatrists Rasim Arikan, M.D.
85. Malpractice Liability in Shared Treatment Eugene L. Lowenkopf, M.D.
86. Assertive Community Treatment Team Patient Employment Outcomes Jessica Hebrank, B.A.
Session 30. Social and Community Psychiatry
87. Defining Disability Down Howard W. Telson, M.D.
88. Marital Disruption and Mental Health: A Nine-Wave Panel Study Terrance J. Wade, Ph.D.
89. Divorce and Marital Instability in Different Subtypes of Major Affective Disorders Zoltan Rihmer, M.D.
Session 31. Issues in Medication Management
90. Compliance and Treatment Discontinuation in Panic-Disorder Patients Giulio Perugi, M.D.
91. Meta-Analysis of Antidepressant Levels in Lactating Mothers’ Breastmilk and Nursing Infants Alicia M. Weissman, M.D.
92. Clinical Problems in the Treatment of Adults With Comorbid ADD Marc D. Schwartz, M.D.
Session 32. Managing Side Effects and Deficits
93. Branched-Chain Amino Acid Treatment of Tardive Dyskinesia Mary Ann Richardson, Ph.D.
94. Nonadrenergic Noncholinergic Sildenafil Treatment of SRI-Associated Sexual Dysfunction H. George Nurnberg, M.D.
95. Rivastigmine Tartrate in Neurocognitive Deficits in Schizophrenia Patients Treated With Clozapine Mohammad Z. Hussain , M.D.
Session 33. Management of Depression
96. Psychosocial Functioning as a Predictor of Response to Nortriptyline in Treatment-Resistant Depression Timothy J. Petersen, Ph.D.
97. Efficacy of Citalopram as an Augmenting Strategy for Menopausal Women With Estrogen-Resistant Depression Claudio N. Soares, M.D.
98. Polypharmacy With Antidepressants John W. Goethe, M.D.
CW42. Educating the Courts: Recent APA Amicus Curiae Briefs APA Commission on Judicial Action Chairperson: Renee L. Binder, M.D.
CW43. Medicare Update 2002 APA Medicare Advisory Committee Chairperson: Edward Gordon, M.D.
CW44. Critical Issues for Treating Domestic Violence Survivors and Their Children APA Committee on Family Violence and Sexual Abuse Co-Chairpersons: Carole L. Warshaw, M.D., Graeme Hanson, M.D.
CW45. Psychiatry’s Response to the Data: Spirituality as a Relevant Clinical Factor APA Committee on Religion, Spirituality, and Psychiatry Chairperson: Irving S. Wiesner, M.D.
CW46. Lesbian, Gay, Bisexual, and Transgendered Residents: Challenges in Training APA Northern California Psychiatric Society’s Committee on Lesbian, Gay, Bisexual, and Transgender Issues Chairperson: Dan H. Karasic, M.D.
CW47. New Trends and Challenges in Residency Education APA Committee on Graduate Education Co-Chairpersons: Joyce A. Tinsley, M.D., Paul E. Holtzheimer III, M.D.
CW48. HIPAA Privacy Rule: What Every Psychiatrist Needs to Know APA Council on Psychiatry and Law and APA Committee on Confidentiality Chairperson: Jeffrey L. Metzner, M.D.
CW49. Meeting the Mental Health Needs of Minorities in the 21st Century APA/Center for Mental Health Services Minority Fellows and APA/AstraZeneca Minority Fellows Chairperson: Michael J. Pratts, M.D.
IW89. Assessing Educational Experiences in Psychiatry Chairperson: Joel Yager, M.D.
IW90. The Psychiatric Fitness-for-Duty Exam Chairperson: Robert C. Larsen, M.D.
IW91. Youth Violence: A Report of the Surgeon General Substance Abuse and Mental Health Services Administration Co-Chairpersons: Marilyn B. Benoit, M.D., Norma Hatot
IW92. Self-Mutilation in Prison Co-Chairpersons: Lee H. Rome, M.D., James E. Dillon, M.D.
IW93. Psychiatric Illness and the Workplace Chairperson: Steven E. Pflanz, M.D.
IW94. Electronic Medical Records Enhance Quality and Productivity: The Time Has Come Chairperson: Daniel A. Deutschman, M.D.
IW95. Dilemmas of Melancholia: Let Philosophy Help Association for the Advancement of Philosophy and Psychiatry Chairperson: Michael F. Myers, M.D.
11 a.m.-2 p.m.
Session 21. Tempering Troubled Minds
28. West 47th Street
9. Killing in the Name of God: Osama Bin Laden and Radical Islam Chairperson: Jerrold M. Post, M.D.
10. ABPN Update: Requirements for ABPN Examination Chairperson: Stephen C. Scheiber, M.D.
11. Latin America Chairperson: Rodrigo A. Muñoz, M.D.
New Research Poster Session 8
12:30 p.m.-2 p.m.
Session 22. Across the Generations
29. Bubbeh Lee and Me
30. The Frog in the Well: The Life and Work of Hoh-Kun Yuen
1 p.m.-5 p.m.
CME Courses 91-96
2 p.m.-3:30 p.m.
L22. Global Implications on the World Health Organization’s World Health Report 2001 on Mental Health Benedetto Saraceno, M.D.,International Psychiatrist Lecture Series
L23. Mania in Youth: A Transition From Ignorance to Enlightenment to Confusion Elizabeth B. Weller, M.D.,Distinguished Psychiatrist Lecture Series
2 p.m.-5 p.m.
Session 23. Psychiatry Goes to the Movies
31. A Beautiful Mind
Session 24. Psychiatry Goes to the Movies
32. King of Masks: Gender and Tradition in China
S57. Sports Through the Life Cycle International Society for Sport Psychiatry
A. The Pros and Cons of Coaching One’s Own Child Ronald L. Kamm, M.D.
B. The Mid-Career Athlete: Coping With Psychiatric Illness Antonia L. Baum, M.D.
C. When the Cheering Stops: Career-Termination Issues in Athletes Joshua W. Calhoun, M.D.
S58. Community Care in Geriatric Psychiatry in the 21st Century
A. Mental Health Disorders Among Rural Elders Kathleen M. Fisher, Ph.D.
B. Primary Care Management of Late-Life Depression Ira R. Katz, M.D.
C. Managing the Behavioral Complications of Dementia Robert P. Roca, M.D.
D. Caring for Elder Depression in the 21st Century Paul A. Kettl, M.D.
E. Depression in Patients With Recent-Onset Bilateral-Age-Related Macular Degeneration Barry W. Rovner, M.D.
S59. Brain Stimulation in Neuropsychiatric Illness
A. Brain Stimulation From Above and Below: Theoretical Issues Mark S. George, M.D.
B. Seizures, ECT, and Transcranial Magnetic Stimulation: Therapeutic Options and New Directions Harold A. Sackeim, Ph.D.
C. Brain Stimulation, Mood, and Epilepsy Michael R. Trimble, M.D.
D. Vagus Nerve Stimulation in Affective Disorders: New Findings Lauren B. Marangell, M.D.
S60. Life-Threatening Hyperthermic Syndromes in Psychiatry
A. 5HT Syndrome Paul E. Keck Jr., M.D.
B. Stimulant-Induced Hypothermia Una D. McCann, M.D.
C. NMS: Still a Syndrome After All These Years? Ronald J. Gurrera, M.D.
D. The Malignant Catatonia Syndrome Stephan C. Mann, M.D.
E. Heatstroke, Heatwaves, and Psychiatric Illness Nigel M. Bark, M.D.
S61. Course of Psychopathology and Functioning in Personality Disorders
A. Six-Year Symptomatic and Functional Course of BPD Mary C. Zanarini, Ed.D.
B. Two-Year Diagnostic Stability of Four DSM-IV Personality Disorders: Schizotypal Personality Disorder, BPD, Avoidant Personality Disorder, and OCD Thomas H. McGlashan, M.D.
C. Using Factor Analysis to Test Dimensional Stability of Personality Disorder Constructs Charles A. Sanislow, Ph.D.
D. Course of Functional Impairment in Personality Disorders Over Two Years Andrew E. Skodol II, M.D.
E. Personality Disorders and Axis I Disorders: Longitudinal Associations of Course M. Tracie Shea, Ph.D.
S62. Circuitry of Failed Cognitive Strategies in Addiction
A. Brain Metabolism During Early Abstinence From Methamphetamine Abuse Edythe London, Ph.D.
B. Impaired Decision Making and Impulse Control Associated With Drug Misuse and Personality Disorders Robert D. Rogers, M.D.
C. Nicotine and Cerebral Blood Flow During a Working Memory Task Monique Ernst, M.D.
D. Differences in Cerebral Glucose Metabolism in Patients On and Off Opiate Replacement Therapy Igor I. Galynker, M.D.
E. Prefrontal Lobe Functioning in Cocaine Users Karen I. Bolla, M.D.
S63. Personality and Personality Disorders in the Community
A. Prevalence and Correlates of Personality Disorders in a Community Sample Jack F. Samuels, Ph.D.
B. The Five-Factor Model of Personality and Personality Disorders in a Community Study Paul T. Costa Jr., Ph.D.
C. Dimensions of DSM-IV Personality Disorders and Their Relationship to the NEO-PI-R Gerald Nestadt, M.D.
D. Comorbidity of Anxiety and Depressive Disorders and Normal Personality Traits Oscar J. Bienvenu III, M.D.
E. The Role of Parenting in the Development of Personality Irving M. Reti, M.D.
S64. Lessons Learned: Looking Back to Move Forward Association of Women Psychiatrists
A. Retrospective Career and Family Transitions for a Clearer Vision Into the 21st Century Marion Z. Goldstein, M.D.
B. Looking Back to Move Forward: The African-American Experience Altha J. Stewart, M.D.
C. Women and National Leadership Roles: Getting There, Functioning Effectively Carol C. Nadelson, M.D.
D. Academic Leadership Opportunities, Gender, Assumptions, and Outcomes Leah J. Dickstein, M.D.
E. The Hand That Rocks the Cradle Rocks the Boat: The Empowerment of Women Ann R. Turkel, M.D.
S65. Taking Control of the Future: Academic Psychiatry and 21st-Century Practice
A. Psychiatry of the 21st Century: The Role of Academic Health Systems Leighton Y. Huey, M.D.
B. Shaping the Future Through Education Michael A. Hoge, Ph.D.
C. Chronic Illness Management and the Death of the Carveout: Models From Academic Psychiatry Thomas Carli, M.D.
D. The Use of Performance Indicators in Quality Improvement and Financial Reimbursement Allen S. Daniels, Ed.D.
E. Academic Psychiatry Managing Managed Care Joseph M. Schwartz, M.D.
S66. Recent Perspectives on Behavioral Addictions
A. Application of Dependence Criteria to Uncontrolled Behaviors Jean Ades, M.D.
B. Pathological Gambling: Relationship to Substance Abuse David A. Gorelick, M.D.
C. Neurobiology of Pathological Gambling Marc N. Potenza, M.D.
D. Compulsive Buying: Clinical Aspects and Comorbidity Michel Lejoyeux, M.D.
E. Are Deviant Sexual Behaviors a Form of Addiction? Florence Thibaut, M.D.
S67. Diagnosis and Treatment of ADHD in Young Children
A. A Population Perspective on Psychopharmacologic Treatment of ADHD in Youths: Review and Update Julio M. Zito, Ph.D.
B. Diagnostic Challenges in Preschool Children Helen L. Egger, M.D.
C. Development and Initiation of the Preschool ADHD Treatment Study (PATS) Laurence L. Greenhill, M.D.
D. Pharmacotherapies in Young Children With ADHD Christopher J. Kratochvil, M.D.
S68. Club Drugs: Trends, Toxicities, and Treatments Substance Abuse and Mental Health Services Administration
A. Trends and Patterns in Club-Drug Use Jane C. Maxwell, Ph.D.
B. Neurotoxic Effects of 4-Methylenedioxymethamphetamine (Ecstasy) George A. Ricaurte, M.D.
C. Club Drugs: Emergency Management Issues Brett A. Roth, M.D.
D. A Review of Psychiatric Symptoms and Treatment for Club-Drug Use Karen A. Miotto, M.D.
E. Club Drugs: Current and Potential Treatments David M. McDowell, M.D.
S69. Naltrexone Treatment of Alcoholism: A Decade of Clinical Progress
A. Efficacy of Naltrexone in the Treatment of Alcoholism Charles P. O’Brien, M.D.
B. Optimizing Naltrexone Treatment of Alcohol Dependence Joseph R. Volpicelli, M.D.
C. Naltrexone: Alcoholism in Patients With Comorbid Mental Illness Stephanie S. O’Malley, Ph.D.
D. International Studies With Naltrexone Philip Morris, Ph.D.
S70. State-of-the-Art Adolescent Substance Abuse Prevention and Treatment Substance Abuse and Mental Health Services Administration
A. Effective Prevention: Center for Substance Abuse Prevention’s National Study of High-Risk Youth Programs J. Fred Springer, Ph.D.
B. Psychiatric Comorbidity and Pharmacology Among Adolescents Presenting to Treatment Deborah R. Simkin, M.D.
C. Main Findings of the Cannabis Youth Treatment Randomized Experiment Michael L. Dennis, Ph.D.
D. Outcomes From the Adolescent Treatment Model Programs Marc Fishman, M.D.
S71. Treatment of Violence and Conduct Disorders in Children and Adolescents
A. Functional Family Therapy in the Treatment of Youth With Conduct Disorder Ellen H. Sholevar, M.D.
B. Community-Based Treatment of Conduct Disorder G. Pirooz Sholevar, M.D.
C. Medication Usage in Conduct Disorders Jacquelyn M. Zavodnick, M.D.
S72. Affective Instability in BPD
A. Affective Instability and Borderline Symptoms and Defenses Harold W. Koenigsberg, M.D.
B. The Relationship Between Childhood Trauma and Affective Instability in BPD Marianne Goodman, M.D.
C. Treating the Affective Instability Domain in BPD Eric Hollander, M.D.
D. Early Maltreatment and the Neurobiology of Affective Instability Martin H. Teicher, M.D.
S73. Clinical and Treatment Challenges With Hispanic Patients Inter-American Council of Psychiatric Organizations
A. The Hispanic Patient and the DSM-IV Carlos Berganza, M.D.
B. Perception of Illness in the Hispanic Patient Carlos Leon-Andrade, M.D.
C. Personality and Hispanic Patients Andres Heerlein , M.D.
D. Psychotherapeutic Intervention With the Hispanic Patient Amelia Mvsacchio, M.D.
E. Psychopharmacological Issues With Hispanic Patients Antonio Pacheco, M.D.
S74. Patients With Chronic Pain: Multidisciplinary Treatment Approaches
A. Pain and Psychiatry: A General Over- view Matthew B. Smith, M.D.
B. An Integrative Model of the Psychobiology of Pain Jeffrey D. Rome, M.D.
C. The Use of Analgesics in Chronic Pain Michel Dubois, M.D.
D. Chronic Pain: Nonanalgesic and Adjuvant Pharmacological Options Michael R. Clark, M.D.
E. Cognitive-Behavioral Approaches to Chronic Pain Allen Lebovits, Ph.D.
S75. Physician Disability: Treatment, Independent Evaluation, Insurance, and Conflicts
A. Area of Conflict Between Disabled Physician Patients and Disability Insurers Richard F. Limoges, M.D.
B. Disability Insurance: Technical and Legal Aspects Mark F. Seltzer, Esq.
C. Treating the Disabled Physician Michael F. Myers, M.D.
D. Performing an Independent Psychiatric Disability Evaluation as a Physician Michael H. Gendel, M.D.
2 p.m.-5:30 p.m.
Review of Psychiatry: Section 4: Mental Health Issues in the Lesbian/Gay/Bisexual/Transgender Community Co-Chairpersons: Billy E. Jones, M.D., Marjorie Hill, Ph.D.
Psychiatric Evaluation of Gay- or Lesbian-Identified Persons for Legal Processing Richard G. Dudley Jr., M.D.
Gay, Lesbian, Bisexual, and Transgender Youth Jeffrey S. Akman, M.D.
History and Update on Sexual Conversion (Reparative) Therapies Jack Drescher, M.D.
Taboo Topics in Psychiatry: Aging and Sexual Orientation Douglas C. Kimmel, Ph.D.
The Intersection of Transgender Mental Health With Homosexuality and Race Donald E. Tarver II, M.D.
3 p.m.-5 p.m.
New Research Poster Session 9
7 p.m.-10 p.m.
IS43. Noncholinergic Treatments for Alzheimer’s Disease: Present Knowledge, Future Hope Supported by Forest Laboratories Inc.
A. The Diagnosis and Treatment of Alzheimer’s Disease: An Overview Barry D. Liebowitz, Ph.D.
B. Current Treatments for Alzheimer’s Disease: Cholinesterase Inhibitors Rachelle S. Doody, M.D.
C. The Neuroanatomy of Alzheimer’s Disease Gary L. Wenk, Ph.D.
D. Beyond Acetylcholine: The Search for Better Treatment Options (Part 1) Jacobo E. Mintzer, M.D.
E. Beyond Acetylcholine: The Search for Better Treatment Options (Part 2) Mary Sano, Ph.D.
IS44. Sleep Disorders and Psychiatric Illnesses: Scientific Foundations Supported by Sepracor Inc.
A. Sleep and Psychiatric Illnesses Thomas Roth, Ph.D.
B. Epidemiology and Economic Burden of Insomnia James K. Walsh, Ph.D.
C. Current Therapeutic Approaches to Sleep Ruth M. Benca, M.D.
IS45. The Burden of Schizophrenia: Why Patients Don’t Get Better Supported by AstraZeneca Pharmaceuticals
A. Defining Nonresponse in Schizophrenia: Why Patients Don’t Do Well Rajiv Tandon, M.D.
B. When Psychosis Doesn’t Improve Alan J. Mendelowitz, M.D.
C. Negative and Cognitive Function Michael D. Jibson, M.D.
D. Comorbidities in Schizophrenia: Depression and Substance Abuse Peter F. Buckley, M.D.
E. Why Patients Stop Their Antipsychotics and What to Do About It Peter J. Weiden, M.D.
IS46. Identification and Management of Daytime Fatigue and Sleepiness in Psychiatry Supported by Cephalon Inc.
A. Sleepiness and Fatigue: Neurobehavioral and Physiological Features David F. Dinges, Ph.D.
B. Primary Sleep Disorders Associated With Excessive Daytime Sleepiness Mary B. O’Malley, M.D.
C. Fatigue and Excessive Daytime Sleepiness in Psychiatric Disorders Karl Doghramji, M.D.
D. Clinical Manifestations of Fatigue in Chronic Fatigue Syndrome Anthony L. Komaroff, M.D.
E. Novel Molecular Targets in Deficit Syndromes Daniel R. Weinberger, M.D.
IS47. Adult ADHD: From Research to Clinical Practice Supported by Shire Richwood
A. Overview and Patterns of Comorbidity in Adults With ADHD Joseph Biederman, M.D.
B. The Neuropsychology of Adult ADHD Larry J. Seidman, Ph.D.
C. A Genetic Perspective of the Validity of Adult ADHD Stephen V. Faraone, Ph.D.
D. Functional and Structural Neuroimaging in ADHD George Bush, M.D.
E. Pharmacotherapy of Adults With ADHD Thomas J. Spencer, M.D.
IS48. Advances in the Understanding and Treatment of Binge-Eating Disorder Supported by Ortho-McNeil Pharmaceutical
A. Binge-Eating Disorder: Diagnosis and Behavior B. Timothy Walsh, M.D.
B. Epidemiology and Risk Factors William P. Carter, M.D.
C. Treatment With Antidepressants James I. Hudson, M.D.
D. Treatment With Appetite Suppressants and Antiepileptics Susan L. McElroy, M.D.
E. Psychological Treatment Denise E. Wilfley, Ph.D.
IS49. Explorations in Dementia: New and Current Perspectives Supported by Eisai Inc., Pfizer Inc.
A. Early Detection and Genetic Risk Assessment in Alzheimer’s Disease Gary W. Small, M.D.
B. Differential Diagnosis of Dementia Syndromes: A Psychiatric Perspective J. Michael Ryan, M.D.
C. Contemporary Issues in Mild Cognitive Impairment: Fact or Fiction? Bradley F. Boeve, M.D.
D. Charting the Course in Cerebrovascular Dementia Gustavo C. Roman, M.D.
E. Alzheimer’s Disease Therapy in the 21st Century: Examining the Evidence Pierre N. Tariot, M.D.
F. Managing Behavioral Disturbances in Dementia: Practical Approaches to Treatment Donna Masterman, M.D. ▪
Download citation file:
Please confirm that your email address is correct, so you can successfully receive this alert.